The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Diagnosis and management of Graves disease: a global overview
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., Rivkees, S. A., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.3.456 · Cited by 1,098
Cooper, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmra042972 · Cited by 1,008
The American Thyroid Association and American Association of Clinical Endocrinologists Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis, Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., et al. (2011) · Thyroid · doi:10.1089/thy.2010.0417 · Cited by 898
Weetman, A. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010263431707 · Cited by 834
Robinson, R. (1993) · BMJ · doi:10.1136/bmj.307.6907.793 · Cited by 816
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO
Bartalena, L., Baldeschi, L., Dickinson, A., Eckstein, A., Kendall-Taylor, P., Marcocci, C., Mourits, M., Perros, P., Boboridis, K., Boschi, A., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0666 · Cited by 795
Self-citationRelation between Therapy for Hyperthyroidism and the Course of Graves' Ophthalmopathy
Bartalena, L., Marcocci, C., Bogazzi, F., Manetti, L., Tanda, M. L., Dell'Unto, E., Bruno-Bossio, G., Nardi, M., Bartolomei, M. P., Lepri, A., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380201 · Cited by 715
Self-citationSystematic review and meta-analysis of psychological therapies for children with chronic pain
Fisher, E., Heathcote, L., Palermo, T. M., de C Williams, A. C., Lau, J., & Eccleston, C. (2014) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsu008 · Cited by 710
Management of Graves’ Ophthalmopathy: Reality and Perspectives*
Bartalena, L., Pinchera, A., & Marcocci, C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0393 · Cited by 677
Self-citationBrent, G. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmcp0801880 · Cited by 594
Occurrence of Ophthalmopathy after Treatment for Graves' Hyperthyroidism
Tallstedt, L., Lundell, G., Tørring, O., Wallin, G., Ljunggren, J.-G., Blomgren, H., & Taube, A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206253262603 · Cited by 521
Current Perspective on the Pathogenesis of Graves’ Disease and Ophthalmopathy
Prabhakar, B. S., Bahn, R. S., & Smith, T. J. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0020 · Cited by 489
Laurberg, P., Wallin, G., Tallstedt, L., Abraham-Nordling, M., Lundell, G., & Tørring, O. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0450 · Cited by 428
Brix, T. H., Kyvik, K. O., Christensen, K., & Hegedüs, L. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7242 · Cited by 406
Cancer Mortality Following Treatment for Adult Hyperthyroidism
Ron, E. (1998) · JAMA · doi:10.1001/jama.280.4.347 · Cited by 377
WARTOFSKY, L., GLINOER, D., SOLOMON, B., NAGATAKI, S., LAGASSE, R., NAGAYAMA, Y., & IZUMI, M. (1991) · Thyroid · doi:10.1089/thy.1991.1.129 · Cited by 374
Bartalena, L., Krassas, G. E., Wiersinga, W., Marcocci, C., Salvi, M., Daumerie, C., Bournaud, C., Stahl, M., Sassi, L., Veronesi, G., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2389 · Cited by 370
Self-citationA 2011 Survey of Clinical Practice Patterns in the Management of Graves' Disease
Burch, H. B., Burman, K. D., & Cooper, D. S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2802 · Cited by 345
Bartalena, L., & Tanda, M. L. (2009) · New England Journal of Medicine · doi:10.1056/nejmcp0806317 · Cited by 336
Self-citationTanda, M. L., Piantanida, E., Liparulo, L., Veronesi, G., Lai, A., Sassi, L., Pariani, N., Gallo, D., Azzolini, C., Ferrario, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3873 · Cited by 328
Self-citationBartalena, L., Marcocci, C., Bogazzi, F., Panicucci, M., Lepri, A., & Pinchera, A. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911163212001 · Cited by 318
Self-citationMortality after the Treatment of Hyperthyroidism with Radioactive Iodine
Franklyn, J. A., Maisonneuve, P., Sheppard, M. C., Betteridge, J., & Boyle, P. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803123381103 · Cited by 309
Ng, B., Chu, A., & Khan, M. M. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002468 · Cited by 301
VITTI, P., RAGO, T., CHIOVATO, L., PALLINI, S., SANTINI, F., FIORE, E., ROCCHI, R., MARTINO, E., & PINCHERA, A. (1997) · Thyroid · doi:10.1089/thy.1997.7.369 · Cited by 293
Age and Gender Predict the Outcome of Treatment for Graves' Hyperthyroidism
Allahabadia, A. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.1038 · Cited by 286
Radioiodine Therapy for Hyperthyroidism
Ross, D. S. (2011) · New England Journal of Medicine · doi:10.1056/nejmct1007101 · Cited by 284
Cancer Risk After Iodine-131 Therapy for Hyperthyroidism
Holm, L.-E., Hall, P., Wiklund, K., Lundell, G., Berg, G., Bjelkengren, G., Cederquist, E., Ericsson, U.-B., Hallquist, A., Larsson, L.-G., et al. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.15.1072 · Cited by 268
Current Trends in the Management of Graves' Disease*
SOLOMON, B., GLINOER, D., LAGASSE, R., & WARTOFSKY, L. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-6-1518 · Cited by 266
Franklyn, J. A., & Boelaert, K. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60782-4 · Cited by 262
Träisk, F., Tallstedt, L., Abraham-Nordling, M., Andersson, T., Berg, G., Calissendorff, J., Hallengren, B., Hedner, P., Lantz, M., Nyström, E., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0747 · Cited by 262
High Dose 131I Therapy for the Treatment of Hyperthyroidism Caused by Graves' Disease
Alexander, E. K. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.3.1073 · Cited by 251
Antithyroid drug regimen for treating Graves’ hyperthyroidism
Abraham, P., Avenell, A., McGeoch, S. C., Clark, L. F., & Bevan, J. S. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003420.pub4 · Cited by 249
The Efficacy of Thyroidectomy for Graves' Disease: A Meta-analysis
Palit, T. K., Miller, C. C., & Miltenburg, D. M. (2000) · Journal of Surgical Research · doi:10.1006/jsre.2000.5875 · Cited by 245
Franklyn, J. A., Maisonneuve, P., Sheppard, M., Betteridge, J., & Boyle, P. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12295-x · Cited by 243
Effect of Abnormal Thyroid Function on the Severity of Graves' Ophthalmopathy
Prummel, M. F. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390170124027 · Cited by 238
Sisson, T. A. T. A. T., Freitas, J., McDougall, I. R., Dauer, L. T., Hurley, J. R., Brierley, J. D., Edinboro, C. H., Rosenthal, D., Thomas, M. J., Wexler, J. A., et al. (2011) · Thyroid · doi:10.1089/thy.2010.0403 · Cited by 234
Bahn, R. S., Burch, H. S., Cooper, D. S., Garber, J. R., Greenlee, C. M., Klein, I. L., Laurberg, P., McDougall, I. R., Rivkees, S. A., Ross, D., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0169 · Cited by 223
Lytton, S. D., Ponto, K. A., Kanitz, M., Matheis, N., Kohn, L. D., & Kahaly, G. J. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2470 · Cited by 219
Hashizume, K., Ichikawa, K., Sakurai, A., Suzuki, S., Takeda, T., Kobayashi, M., Miyamoto, T., Arai, M., & Nagasawa, T. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104043241403 · Cited by 216
Putting Propylthiouracil in Perspective
Cooper, D. S., & Rivkees, S. A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0850 · Cited by 212
A systematic review of drug therapy for Graves’ hyperthyroidism
Abraham, P., Avenell, A., Park, C. M., Watson, W. A., & Bevan, J. S. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01993 · Cited by 211
Read, C. H., Tansey, M. J., & Menda, Y. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031223 · Cited by 204
Walter, M. A., Briel, M., Christ-Crain, M., Bonnema, S. J., Connell, J., Cooper, D. S., Bucher, H. C., Müller-Brand, J., & Müller, B. (2007) · BMJ · doi:10.1136/bmj.39114.670150.be · Cited by 202
Acharya, S. H., Avenell, A., Philip, S., Burr, J., Bevan, J. S., & Abraham, P. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03279.x · Cited by 200
Boelaert, K., Torlinska, B., Holder, R. L., & Franklyn, J. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2495 · Cited by 196
Tozzoli, R., Bagnasco, M., Giavarina, D., & Bizzaro, N. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.07.003 · Cited by 195
Vitti, P., Rago, T., Mazzeo, S., Brogioni, S., Lampis, M., De Liperi, A., Bartolozzi, C., Pinchera, A., & Martino, E. (1995) · Journal of Endocrinological Investigation · doi:10.1007/bf03349833 · Cited by 182
Tallstedt, L., Lundell, G., Blomgren, H., & Bring, J. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1300494 · Cited by 171
An Optimal Treatment for Pediatric Graves’ Disease Is Radioiodine
Rivkees, S. A., & Dinauer, C. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1239 · Cited by 164
Increased cancer incidence after radioiodine treatment for hyperthyroidism
Metso, S., Auvinen, A. P., Huhtala, H., Salmi, J., Oksala, H., & Jaatinen, P. (2007) · Cancer · doi:10.1002/cncr.22635 · Cited by 161
A Population-Based Study of Outcomes from Thyroidectomy in Aging Americans: At What Cost?
Ann Sosa, J., Mehta, P. J., Wang, T. S., Boudourakis, L., & Roman, S. A. (2008) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2007.11.023 · Cited by 159
Erbil, Y., Ozluk, Y., Giriş, M., Salmaslıoglu, A., Issever, H., Barbaros, U., Kapran, Y., Özarmağan, S., & Tezelman, S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0229 · Cited by 157
Perros, P., Kendall-Taylor, P., Neoh, C., Frewin, S., & Dickinson, J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0507 · Cited by 156
Increased Cardiovascular and Cancer Mortality after Radioiodine Treatment for Hyperthyroidism
Metso, S., Jaatinen, P., Huhtala, H., Auvinen, A. P., Oksala, H., & Salmi, J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2321 · Cited by 155
Treatment of Hyperthyroidism in Pregnancy and Birth Defects
Clementi, M., Gianantonio, E. D., Cassina, M., Leoncini, E., Botto, L. D., & Mastroiacovo, P. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0652 · Cited by 154
Nyström, H. F., Jansson, S. K. G., & Berg, G. E. B. (2013) · Clinical Endocrinology · doi:10.1111/cen.12060 · Cited by 153
Amiodarone and the thyroid: a 2012 update.
Bogazzi, F., Tomisti, L., Bartalena, L., Aghini-Lombardi, F., & Martino, E. (2012) · PubMed · doi:10.3275/8298 · Cited by 149
Self-citationEffect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine
Azizi, F., Ataie, L., Hedayati, M., Mehrabi, Y., & Sheikholeslami, F. H. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01904 · Cited by 146
Ota, H., Amino, N., Morita, S., Kobayashi, K., Kubota, S., Fukata, S., Kamiyama, N., & Miyauchi, A. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02832.x · Cited by 144
Remission of Graves’ disease during anti-thyroid drug therapy. Time to reconsider the mechanism?
Laurberg, P. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02295 · Cited by 139
Bogazzi, F., Bartalena, L., Brogioni, S., Burelli, A., Manetti, L., Tanda, M. L., Gasperi, M., & Martino, E. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1400452 · Cited by 134
Self-citationMinimally Invasive Video‐Assisted Thyroidectomy for Benign Thyroid Disease: An Evidence‐Based Review
Miccoli, P., Minuto, M. N., Ugolini, C., Pisano, R., Fosso, A., & Berti, P. (2008) · World Journal of Surgery · doi:10.1007/s00268-008-9479-y · Cited by 133
Nedrebo, B., Holm, P., Uhlving, S., Sorheim, J., Skeie, S., Eide, G., Husebye, E., Lien, E., & Aanderud, S. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1470583 · Cited by 132
Menconi, F., Marinò, M., Pinchera, A., Rocchi, R., Mazzi, B., Nardi, M., Bartalena, L., & Marcocci, C. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1800 · Cited by 132
Self-citationDelineating the autoimmune mechanisms in Graves’ disease
MORSHED, S. A., Latif, R., & Davies, T. F. (2012) · Immunologic Research · doi:10.1007/s12026-012-8312-8 · Cited by 131
Lai, A., Sassi, L., Compri, E., Marino, F., Sivelli, P., Piantanida, E., Tanda, M. L., & Bartalena, L. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2130 · Cited by 129
Self-citationTakata, K., Kubota, S., Fukata, S., Kudo, T., Nishihara, E., Ito, M., Amino, N., & Miyauchi, A. (2009) · Thyroid · doi:10.1089/thy.2008.0364 · Cited by 128
Thyroid dermopathy and acropachy
Fatourechi, V. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.10.001 · Cited by 123
Prevalence and natural history of Graves' orbitopathy in the XXI century.
Piantanida, E., Tanda, M. L., Lai, A., Sassi, L., & Bartalena, L. (2013) · PubMed · doi:10.3275/8937 · Cited by 122
Self-citationMarcocci, Bruno‐Bossio, Manetti, Tanda, M. L., Miccoli°, Iacconi, Bartolomei, Nardi, Pinchera, & Bartalena (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00843.x · Cited by 118
Glinoer, D., Hesch, D., Lagasse, R., & Laurberg, P. (1987) · European Journal of Endocrinology · doi:10.1530/acta.0.115s006 · Cited by 117
Adverse Effects of Thyroid Hormone Preparations and Antithyroid Drugs
Bartalena, L., Bogazzi, F., & Martino, E. (1996) · Drug Safety · doi:10.2165/00002018-199615010-00004 · Cited by 116
Self-citationComparison of Radioiodine with Radioiodine plus Lithium in the Treatment of Graves' Hyperthyroidism
Bogazzi, F., Bartalena, L., Brogioni, S., Scarcello, G., Burelli, A., Campomori, A., Manetti, L., Rossi, G., Pinchera, A., & Martino, E. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5446 · Cited by 115
Self-citationEmiliano, A. B., Governale, L. A., Parks, M. A., & Cooper, D. S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2752 · Cited by 112
Rotondi, M., Cappelli, C., Pirali, B., Pirola, I., Magri, F., Fonte, R., Castellano, M., Rosei, E. A., & Chiovato, L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0966 · Cited by 109
Carbimazole embryopathy: An emerging phenotype
Foulds, N. C., Walpole, I., Elmslie, F., & Mansour, S. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30418 · Cited by 108
Efficacy and Safety of Orbital Radiotherapy for Graves' Orbitopathy
Tanda, M. L., & Bartalena, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2758 · Cited by 104
Self-citationGenovese, B. M., Noureldine, S. I., Gleeson, E., Tufano, R. P., & Kandil, E. H. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2606-x · Cited by 101
de Lange, J., & Baas, E. M. (2010) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2009.12.025 · Cited by 100
Color Flow Doppler Sonography for the Etiologic Diagnosis of Hyperthyroidism
Erdoğan, M. F., Anıl, C., Cesur, M., Başkal, N., & Erdoğan, G. (2007) · Thyroid · doi:10.1089/thy.2006.0104 · Cited by 98
The Dilemma of How to Manage Graves' Hyperthyroidism in Patients with Associated Orbitopathy
Bartalena, L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2329 · Cited by 93
Self-citationBogazzi, F., Giovannetti, C., Fessehatsion, R., Tanda, M. L., Campomori, A., Compri, E., Rossi, G., Ceccarelli, C., Vitti, P., Pinchera, A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1655 · Cited by 88
Self-citationMazza, E., Carlini, M., Flecchia, D., Blatto, A., Zuccarini, O., Gamba, S., Beninati, S., & Messina, M. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03346433 · Cited by 88
Laurberg, P., Berman, D. C., Andersen, S., & Pedersen, I. B. (2011) · Thyroid · doi:10.1089/thy.2011.0039 · Cited by 87
Current and emerging treatment options for Graves’ hyperthyroidism
Abraham, P., & Acharya (2009) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s5229 · Cited by 84
Tsai, W., Pei, D., Wang, T., Wu, D., Li, J., Wei, C. L., Lee, C., Chen, S., & Kuo, S. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02249.x · Cited by 83
Adjunctive cholestyramine therapy for thyrotoxicosis*
Solomon, B. L., Wartofsky, L., & Burman, K. D. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00970.x · Cited by 83
Boelaert, K., Maisonneuve, P., Torlinska, B., & Franklyn, J. A. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3459 · Cited by 82
Schott, M., Hermsen, D. F., Broecker‐Preuss, M., Casati, M., Cámara, J., Eckstein, A. K., Gassner, D., Golla, R., Graeber, C., van Helden, J., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03512.x · Cited by 82
Vaidya, B., Williams, G. R., Abraham, P., & Pearce, S. H. S. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03097.x · Cited by 81
Treatment Options for Graves Disease: A Cost-Effectiveness Analysis
In, H., Pearce, E. N., Wong, A. K. G., Burgess, J. F., McAneny, D. B., & Rosen, J. E. (2009) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2009.03.025 · Cited by 81
Kahaly, G. J., Bartalena, L., & Hegedüs, L. (2011) · Thyroid® · doi:10.1089/thy.2011.2106.ed3 · Cited by 80
Self-citationElbers, L. P. B., Mourits, M. P., & Wiersinga, W. M. (2010) · Thyroid · doi:10.1089/thy.2010.0181 · Cited by 80
Genetics of thyroid autoimmunity and the role of the TSHR
Brand, O. J., & Gough, S. C. L. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.01.013 · Cited by 76
A questionnaire survey on the management of Graves’ orbitopathy in Europe
_, _., Perros, P., Baldeschi, L., Boboridis, K. G., Dickinson, A. J., Hullo, A., Kahaly, G. J., Kendall-Taylor, P., Krassas, G. E., Lane, C., et al. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02201 · Cited by 76
Barczyński, M., Konturek, A., Hubalewska–Dydejczyk, A., Gołkowski, F., & Nowak, W. (2012) · British journal of surgery · doi:10.1002/bjs.8660 · Cited by 74
De Bellis, A., Conzo, G., Cennamo, G., Pane, E., Bellastella, G., Colella, C., Iacovo, A. D., Paglionico, V. A., Sinisi, A. A., Wall, J. R., et al. (2012) · Endocrine · doi:10.1007/s12020-011-9559-x · Cited by 69
Role of Thyroid Doppler in Differential Diagnosis of Thyrotoxicosis
Kumar, K. V. S. H., Vamsikrishna, P., Muthukrishnan, J., Verma, A., Rayudu, B. R., & Modi, K. D. (2009) · Endocrine Practice · doi:10.4158/ep.15.1.6 · Cited by 67
Comparison of Radioiodine with Radioiodine plus Lithium in the Treatment of Graves' Hyperthyroidism
Bogazzi, F. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.2.499 · Cited by 67
Leo, M., Marcocci, C., Pinchera, A., Nardi, M., Megna, L., Rocchi, R., Latrofa, F., Altea, M. A., Mazzi, B., Sisti, E., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2077 · Cited by 66
The role of imaging in Graves’ disease: A cost-effectiveness analysis
Cappelli, C., Pirola, I., De Martino, E., Agosti, B., Delbarba, A., Castellano, M., & Rosei, E. A. (2008) · European Journal of Radiology · doi:10.1016/j.ejrad.2007.03.015 · Cited by 65
Fulminant Hepatic Failure Associated with Propylthiouracil
Ruiz, J. K., Rossi, G. V., Vallejos, H. A., Brenet, R. W., Lopez, I. B., & Escribano, A. A. (2003) · Annals of Pharmacotherapy · doi:10.1177/106002800303700213 · Cited by 63
Weetman, A. P., Pickerill, A. P., Watson, P. H., Chatterjee, K., & Edwards, O. M. (1994) · QJM · doi:10.1093/oxfordjournals.qjmed.a068938 · Cited by 62
Pradeep, P. V., Agarwal, A., Baxi, M., Agarwal, G., Gupta, S. K., & Mishra, S. K. (2007) · World Journal of Surgery · doi:10.1007/s00268-006-0572-9 · Cited by 61
Severe Embryopathy and Exposure to Methimazole in Early Pregnancy
Karlsson, F. A., Axelssön, O., & Melhus, H. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8126 · Cited by 57
Measurement of Thyroid Blood Flow Area Is Useful for Diagnosing the Cause of Thyrotoxicosis
Kurita, S., Sakurai, M., Kita, Y., Ota, T., Ando, H., Kaneko, S., & Takamura, T. (2005) · Thyroid · doi:10.1089/thy.2005.15.1249 · Cited by 56
Dose of intravenous steroids and therapy outcome in Graves’ orbitopathy
Zang, S., Ponto, K. A., Pitz, S., & Kahaly, G. J. (2011) · Journal of Endocrinological Investigation · doi:10.1007/bf03346732 · Cited by 55
Techniques to quantify TSH receptor antibodies
Ajjan, R., & Weetman, A. P. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0886 · Cited by 54
Moleti, M., Mattina, F., Salamone, I., Violi, M. A., Nucera, C., Baldari, S., Schiavo, M. G. L., Regalbuto, C., Trimarchi, F., & Vermiglio, F. (2003) · Thyroid · doi:10.1089/105072503322240004 · Cited by 48
Bonnema, S., Bennedbaek, F., Gram, J., Veje, A., Marving, J., & Hegedus, L. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490485 · Cited by 47
The Management of Hyperthyroidism Due to Graves' Disease in Japan in 1988.
Nagayama, Y., Izumi, M., & Nagataki, S. (1989) · Endocrinologia Japonica · doi:10.1507/endocrj1954.36.299 · Cited by 47
Bogazzi, F., & Vitti, P. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0692 · Cited by 46
Grodski, S., Stalberg, P. L. H., Robinson, B. G., & Delbridge, L. (2007) · Thyroid · doi:10.1089/thy.2006.0141 · Cited by 46
Takata, K., Amino, N., Kubota, S., Sasaki, I., Nishihara, E., Kudo, T., Ito, M., Fukata, S., & Miyauchi, A. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03745.x · Cited by 45
Noh, J. Y., Miyazaki, N., Ito, K., Takeda, K., Hiramatsu, S., Morita, S., Miyauchi, A., Murakami, T., Inomata, K., Noguchi, S., et al. (2008) · Thyroid · doi:10.1089/thy.2008.0119 · Cited by 44
Okosieme, O. E., Chan, D., Price, S., Lazarus, J. H., & Premawardhana, L. D. K. E. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03623.x · Cited by 41
Hermsen, D. F., Broecker‐Preuss, M., Casati, M., Cámara, J., Eckstein, A. K., Gassner, D., van Helden, J., Inomata, K., Jarausch, J., Kratzsch, J., et al. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.11.025 · Cited by 41
Kamijo, K., Murayama, H., Uzu, T., Togashi, K., & Kahaly, G. J. (2010) · Thyroid · doi:10.1089/thy.2010.0059 · Cited by 38
KASHIWAI, T., Hidaka, Y., Takano, T., Tatsumi, K.-I., Izumi, Y., Shimaoka, Y., Tada, H., Takeoka, K., & Amino, N. (2003) · Endocrine Journal · doi:10.1507/endocrj.50.45 · Cited by 38
Glucocorticoids for Graves’ Ophthalmopathy: How and When1
Bartalena, L. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1553 · Cited by 36
Self-citationYamashita, S., Amino, N., & Shong, Y. K. (2011) · Thyroid · doi:10.1089/thy.2011.2106.ed1 · Cited by 34
Boi, F., Loy, M., Piga, M. A., Serra, A., Atzeni, F., & Mariotti, S. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430339 · Cited by 33
Jin, J., Sandoval, V., Lawless, M. E., Sehgal, A. R., & McHenry, C. R. (2012) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2011.10.010 · Cited by 33
Martin, N. M., Patel, M. Y., Nijher, G. M. K., Misra, S., Murphy, E., & Meeran, K. M. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04385.x · Cited by 31
Sztal‐Mazer, S., Nakatani, V. Y., Bortolini, L. G. C., Boguszewski, C. L., Graf, H., & de Carvalho, G. A. (2012) · Thyroid · doi:10.1089/thy.2011.0362 · Cited by 28
Management of Graves' disease in Australia
Walsh, J. P. (2000) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.2000.tb00856.x · Cited by 27
Pearce, E. N., Hennessey, J. V., & McDermott, M. T. (2011) · Thyroid · doi:10.1089/thy.2011.0104 · Cited by 24
Al‐Adhami, A., Craig, W. L., & Krukowski, Z. H. (2012) · Thyroid · doi:10.1089/thy.2011.0153 · Cited by 22
Management of Grave’s Disease Is Improved by Total Thyroidectomy
Annerbo, M., Stalberg, P. L. H., & Hellman, P. (2012) · World Journal of Surgery · doi:10.1007/s00268-012-1617-x · Cited by 22
Cardiovascular and Cancer Mortality after Radioiodine Treatment of Hyperthyroidism
Vanderpump, M. P. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0837 · Cited by 19
How antithyroid drugs work in Graves' disease
Weetman, A. P. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02330.x · Cited by 18
Franklyn, J. A. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03633.x · Cited by 15
The management of Graves' disease in New Zealand: results of a national survey.
Hc, F., Jw, D., & Cm, F. (1991) · PubMed · Cited by 13
Dasgupta, S., & Savage, M. W. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2005.00545.x · Cited by 12
Emerging pharmacotherapy for treatment of Graves’ disease
Bahn, R. S. (2012) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.12.54 · Cited by 10
Cited by
Smith, T. J., & Hegedüs, L. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1510030 · Cited by 1,257
2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism
Kahaly, G. J., Bartalena, L., Hegedüs, L., Leenhardt, L., Poppe, K., & Pearce, S. H. (2018) · European Thyroid Journal · doi:10.1159/000490384 · Cited by 940
Self-citationDe Leo, S., Lee, S. Y., & Braverman, L. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00278-6 · Cited by 883
Extrathyroidal manifestations of Graves’ disease: a 2014 update
Bartalena, L., & Fatourechi, V. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0097-2 · Cited by 279
Self-citationConcomitant thyroid disorders and inflammatory bowel disease: a literature review
Shizuma, T. (2016) · BioMed Research International · doi:10.1155/2016/5187061 · Cited by 47
Metadata
- Authors
- Bartalena, L.
- Venue
- Nature Reviews Endocrinology
- Published
- 2013-10-15
- Volume
- 9
- Issue
- 12
- Pages
- 724-734
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- OpenAlex
- W2089212170
- Cited by
- 296
- References
- 135
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.